COVID-19 Sample Collection Kits Market Set to Surge Significantly During 2022 to 2030
COVID-19 Sample Collection Kits Industry Overview The global COVID-19 sample collection kits market size was valued at USD 6.48 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of (8.7)% from 2022 to 2030. SARS-CoV-2 sampling is the most critical step in the effective diagnosis of active infection. False and imprecise specimen collection may lead to wrong or misleading test results. As a result, the Centers for Disease Control and Prevention (CDC) and other healthcare organizations have introduced standard procedures and guidance for effective specimen collection and streamlining the usage of COVID-19 sample collection solutions, thereby driving the market. In October 2021, the FDA granted Labcorp an Emergency Use Authorization (EUA) for a combination home collection kit that may detect COVID-19 plus influenza A/B in children as young as two years old. Those who match clinical standards, such as having symptoms, being contacted by...